Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Delivers Screening Targets to Bayer

Premium

RESEARCH TRIANGLE PARK, NC--Paradigm Genetics announced that it has delivered more screening targets to Bayer in accordance with a research collaboration aimed at developing herbicides. Bayer is developing additional assays on target genes discovered in Paradigm's GeneFunction Factory.

The collaboration began in October, 1998 and reached two milestones in February when Paradigm provided the first assay and delivered release 1.1 of a customized FunctionFinder bioinformatics system.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.